Page 8 - Uphat News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Uphat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Uphat Today - Breaking & Trending Today
Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Rating) have received a consensus rating of “Moderate Buy” from the six ratings firms that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price […] ....
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Rating) has received a consensus recommendation of “Moderate Buy” from the six ratings firms that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month price target […] ....
Needham & Company LLC reiterated their buy rating on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Get Rating) in a research report released on Wednesday morning, Benzinga reports. They currently have a $23.00 target price on the stock. A number of other research firms also recently weighed in on PHAT. Craig Hallum assumed coverage on shares […] ....
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Rating) CFO Molly Henderson sold 3,439 shares of the stock in a transaction that occurred on Thursday, April 6th. The stock was sold at an average price of $7.27, for a total value of $25,001.53. Following the transaction, the chief financial officer now owns 72,576 shares in the company, […] ....